Cagrilintide is a protracted-acting amylin receptor agonist produced by Novo Nordisk for weight management and metabolic health and fitness. It mimics the action of Normally developing amylin hormone, that's co-secreted with insulin from pancreatic beta cells. → Increases glucose regulation: Slowing digestion also smooths out put up-food blood sugar spikes, https://cagrilintide-dosage-chart42973.eedblog.com/40252813/the-basic-principles-of-cagrilintide-peptide